Securing FDA organizational revamp on Woodcock’s to-do list

Acting FDA Commissioner Janet Woodcock told BioCentury Friday she plans to remain at the agency long enough to ensure the success of initiatives she has launched to modernize the agency’s organizational structure and finances.

“I certainly am not going to walk away in the middle of a project if its success is still unclear,” Woodcock said...